Hyamax at 21th AMWC Monaco

Hyamax at 21th AMWC Monaco


the world’s leading conference specializing in aesthetic and anti-aging medicine.

AMWC is the world's leading conference on aesthetic and anti-aging medicine, with 20 years of global pioneering experience.
March 30, 2023

This internationally renowned congress

holds its 21st edition in Monaco 

More than 12,000 participants

250 speakers

250 of the industry's most trusted companies

Participation in a top-notch scientific program and a lively exhibition
Hyamax  exhibits at AMWC for many years

Hyamax is also here as promised this year

From the beautiful shores of Lake Geneva, Switzerland to the French coast of Monaco

What has changed is the evolution of medicine and technology

What remains the same is Hyamax's pure pursuit of safety and aesthetics
Hyamax has always been deeply involved in the non-surgical medical aesthetic industry, ensuring its leading position in the field of injectable hyaluronic acid fillers, while also expanding its R&D and manufacturing field to light medical aesthetics.

In addition to the classic cross-linked hyaluronic acid fillers, monophasic cross-linked hyaluronic acid fillers and lidocaine hyaluronic acid fillers, Hyamax also introduced Hyamax Mesotherapy Series and non-cross-linked hyaluronic acid fillers "Hyavital".

Based on French mesotherapy, Hyamax has developed five "Mesotherapy" products, HA18, PDRN40, PDRN60, COGN3, COGN9, to meet the requirements of the light medical market for skin improvement, moisturizing, brightening, rejuvenating, lifting and firming, anti-inflammatory, and anti-acne.

Hyamax non-cross-linked hyaluronic acid filler "Hyavital" is one of the most concentrated hyaluronic acid fillers on the market today, containing up to 64mg each. It does not contain the cross-linking agent BDDE and is free of any chemical residues. It can effectively improve skin aging, sagging and neck line, hydrate the skin, firm and lift. Immediately after the launch, it became the "star" product of Hyamax product family.

After the AMWC conference, Hyamax will incorporate the advanced technology and experience we have absorbed into our subsequent product development and manufacturing process to better meet the requirements of the medical aesthetic market.